Abstract
Existential fear, systematically exacerbated in the interests of corporate profit and professional and political advancement, is driving medicine to deliver significant harms alongside undoubted benefits. The inflation and exploitation of risk drive overdiagnosis and overtreatment which cause harm to patients, undermine the role of doctors and threaten the viability of healthcare systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sen A. The idea of justice. London: Allen Lane; 2009.
Agathon 448–400 BCE. Quoted by Aristotle in Poetics, 335BCE.
Illich I. Limits to medicine. London: Marion Boyars Publishers; 1975.
Freemantle N, Hill S. Medicalisation, limits to medicine, or never enough money to go around? BMJ. 2002;324:864–5.
Eliot G. Daniel Deronda. 1876.
Butler K. What broke my father’s heart. The New York Times. June 18, 2010.
Callahan D. The Difficult Child of Medical Progress. Bioethics Forum. 2012.
Royal College of Psychiatrists. Vulnerable patients, vulnerable doctors: good practice in our clinical relationships. London: Royal College of Psychiatrists; 2002.
Lupton D. Risk as moral danger: the social and political functions of risk discourse in public health. Int J Health Serv. 1993;23(3):425–35.
Forster EM. Howards end. 1910.
Sen A. Health: perception versus observation. BMJ. 2002;324:860–1.
Korzybski A. Science and sanity: an introduction to non-Aristotelian systems and general semantics. New York: International Non-Aristotelian Library Publications; 1933.
Schön DA. The reflective practitioner: how professionals think in action. New York: Basic Books; 1983.
Pakman M. On imagination: reconciling knowledge and life, or what does Gregory Bateson stand for? Fam Process. 2004;43(4):413–23.
Kleinman A. Patients and healers in the context of culture. Berkeley: University of California Press; 1980.
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366. doi:10.1136/bmj.g366.
Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302(15):1685–92.
Scheffler RM, Hinshaw SP, Modrek S, Levine P. The global market for ADHD medications. Health Aff. 2007;26(2):450–7.
Gawande A. Letting Go. New Yorker. 27 July 2010.
Conrad J. The Nigger of the ‘Narcissus’. 1897.
McCormick J. Health promotion: the ethical dimension. Lancet. 1994;344:390–1.
Bauman Z. Alone again: ethics after uncertainty. London: Demos; 1994.
Williams J. Stoner. New York: The Viking Press, 1965.
Bellow S. Mr Sammler’s Planet. New York: The Viking Press, 1970.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Heath, I. (2018). The Role of Fear in Overdiagnosis and Overtreatment. In: Klotz, L. (eds) Active Surveillance for Localized Prostate Cancer. Current Clinical Urology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-62710-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-62710-6_3
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-62709-0
Online ISBN: 978-3-319-62710-6
eBook Packages: MedicineMedicine (R0)